A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) is a family of secreted enzymes with proteolytic functions that modulate the extracellular matrix (ECM). These enzymes share a conserved protein structure featuring a metalloproteinase domain and thrombospondin type 1 repeats. ADAMTS enzymes are involved in a wide range of physiological processes, such as tissue remodeling, cell adhesion, angiogenesis, and coagulation. These enzymes cleave large ECM proteins like aggrecan, versican, and procollagen, thereby altering the structural and functional properties of tissues. The expression and activity of ADAMTS enzymes are regulated by various signaling pathways, transcription factors, and post-translational modifications. Factors like growth factors, cytokines, and even certain small molecules can indirectly influence the activity of ADAMTS by affecting gene expression, stability, or substrate availability.
ADAMTS-1 Activators refers to a category of molecules that can either directly or indirectly increase the activity or expression of ADAMTS-1, a specific member of the ADAMTS family. This enzyme is primarily involved in ECM remodeling and can cleave several substrates including aggrecan and versican. Small molecules that act as ADAMTS-1 activators can operate through various mechanisms. Some might inhibit opposing pathways, allowing for increased ADAMTS-1 activity, while others might work through epigenetic regulation. For instance, certain TGF-β inhibitors can upregulate ADAMTS-1 expression by interfering with signaling pathways that usually suppress it. Additionally, small molecules that stabilize the ECM could indirectly activate ADAMTS-1 by preserving its substrates. The interaction of these activators with ADAMTS-1 or the pathways that control it contributes to the overall regulation of the enzyme and thereby influences the structure and function of the ECM.
Items 1 to 10 of 13 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A derivative of vitamin A that can modulate gene expression and thereby potentially affect ADAMTS levels or activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol Esters can upregulate the expression of some ADAMTS proteins, although they are mainly used experimentally. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
A TGF-β inhibitor that can potentially upregulate certain ADAMTS enzymes by suppressing TGF-β signaling pathways that may downregulate ADAMTS expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor that may facilitate ADAMTS gene expression by altering the epigenetic landscape. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
PDGF Small Molecule Inhibitors could potentially influence ADAMTS activity by interfering with growth factor-mediated ECM remodeling. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
PDGF Small Molecule Inhibitors could potentially influence ADAMTS activity by interfering with growth factor-mediated ECM remodeling. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
PDGF Small Molecule Inhibitors could potentially influence ADAMTS activity by interfering with growth factor-mediated ECM remodeling. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
An Nrf2 activator that might influence ADAMTS enzymes, particularly under conditions of oxidative stress. | ||||||
Dimethyloxaloylglycine (DMOG) | 89464-63-1 | sc-200755 sc-200755A sc-200755B sc-200755C | 10 mg 50 mg 100 mg 500 mg | $84.00 $301.00 $374.00 $779.00 | 25 | |
A hydroxylase inhibitor that could affect the post-translational modifications of ADAMTS enzymes, thereby potentially influencing their stability or activity. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
As a reactive oxygen species (ROS) scavenger, this molecule could potentially activate ADAMTS enzymes by reducing oxidative stress that may impair their activity. | ||||||